Announcements Trials
Browse Landscape

Phase

Phase 1 17Phase 2 10Phase 3 6Phase 1/2 2Phase NA 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 23NIH 3NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 38Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Colorectal Neoplasms 14Prostatic Neoplasms 13Head and Neck Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Sarcoma 10Neoplasms 9Ovarian Neoplasms 8Uterine Cervical Neoplasms 7Rectal Neoplasms 7Lymphoma 7Lung Neoplasms 7Leukemia 7Colonic Neoplasms 7Urinary Bladder Neoplasms 6Stomach Neoplasms 6Pain 6Neoplasm Metastasis 6Fallopian Tube Neoplasms 6Hodgkin Disease 5Burkitt Lymphoma 5Breast Carcinoma In Situ 5Brain Neoplasms 5Testicular Neoplasms 4Teratoma 4Squamous Cell Carcinoma of Head and Neck 4Recurrence 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Pancreatic Neoplasms 4

Interventions

Vincristine 1Temozolomide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × NETWORK × Oligodendroglioma × Clear all
NCT00077207 2018-05-16

Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma

Children's Oncology Group

Phase NA Completed
66 enrolled 13 charts
CNS

Brain Neoplasms, Oligodendroglioma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡